A novel prediction model for myocardial fibrosis in patients suspected of myocarditis
Abstract
Purpose: This study aimed at establishing a predictive method that consists of clinical, electrocardiographic (ECG), and laboratory parameters for myocardial fibrosis, especially as detected on cardiac magnetic resonance imaging (CMRI), in patients examined with suspicion of myocarditis.
Materials and Methods: This study is a retrospective, single-centre study that includes patients admitted to our centre with suspected myocarditis between March 2020 and November 2023. Participants were categorised into two groups (myocardial fibrosis positive and myocardial fibrosis negative), and a detailed comparison of comorbidities, ECG changes, and laboratory parameters was performed. Multivariate analysis was conducted to identify independent predictors of myocardial fibrosis. A nomogram was constructed using the coefficients from the multivariate analysis to estimate the probability of myocardial fibrosis presence based on key predictors.
Results: This study included 98 participants with a median age of 30 years, predominantly male (80.6%), with 14.3% having hypertension, 8.2% having diabetes mellitus, and 10.2% being smokers. The myocardial fibrosis-negative group exhibited higher levels of left ventricular ejection fraction and lymphocyte count. Conversely, the myocardial fibrosis-positive group showed higher levels of ECG changes at admission, peak C-reactive protein (CRP), CRP velocity, peak troponin, N-terminal pro-brain natriuretic peptide (NT-proBNP), monocytes, and platelets (PLT). In multivariate analysis, PLT, lymphocyte, monocyte, peak troponin, and ECG changes were identified as independent predictors of myocardial fibrosis. Receiving operating characteristic (ROC) curve analysis showed the model's diagnostic accuracy for predicting myocardial fibrosis (area under the ROC (AUC): 0.959, 95% confidence interval (CI), and p<0.001).
Conclusion: This comprehensive analysis highlights the relationships between clinical and laboratory parameters and myocardial fibrosis and presents a predictive model with high diagnostic accuracy.
Keywords
Endomyocardial fibrosis , magnetic resonance ımaging , myocarditis
Kaynakça
- 1. McDonagh TA, Macro M, Adamo M, Gardner SR, Baumbach A, Böhm M et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–3726
- 2. Tschöpe C, Ammirati E, Bozkurt B, Caforoi ALP, Cooper LT, Felix SB et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021;18:169–93.
- 3. Gupta S, Markham DW, Drazner MH, Mammen PPA. Fulminant myocarditis. Nat Clin Pract Cardiovasc Med. 2008;5:693-706.
- 4. Caforio ALP, Marcolongo R, Basso C, Iliceto S. Clinical presentation and diagnosis of myocarditis. Heart. 2015;101:1332–44.
- 5. Tschope C, Cooper LT, Torre-Amione G, Van Linthout S. Management of myocarditis-related cardiomyopathy in adults. Circ Res. 2019;124:1568–83.
- 6. Biesbroek PS, Beek AM, Germans T, Niessen HWM, van Rossum AC. Diagnosis of myocarditis: current state and future perspectives. Int J Cardiol. 2015;191:211–9.
- 7. Yilmaz A, Ferreira V, Klingel K, Kandolf R, Neubauer S, Sechtem U. Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis. Heart Fail Rev. 2012;18:747-60.
- 8. Krishnamurthy R, Cheong B, Muthupillai R. Tools for cardiovascular magnetic resonance imaging. Cardiovasc Diagn Ther. 2014;4:104-25.
- 9. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB et al. The current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2013;34:2636–48.
- 10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on the detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.
